142 related articles for article (PubMed ID: 8499331)
1. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells.
Koehorst SG; Jacobs HM; Thijssen JH; Blankenstein MA
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):227-33. PubMed ID: 8499331
[TBL] [Abstract][Full Text] [Related]
2. The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas.
Jacobs HM; van Spriel AB; Koehorst SG; Thijssen JH; Blaauw G; Blankenstein MA
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):167-72. PubMed ID: 10704905
[TBL] [Abstract][Full Text] [Related]
3. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
Poola I; Speirs V
J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
Fasco MJ
Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
Rice LW; Jazaeri AA; Shupnik MA
Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
[TBL] [Abstract][Full Text] [Related]
6. Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach.
Poola I; Koduri S; Chatra S; Clarke R
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):249-58. PubMed ID: 10822014
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor independent expression of progestin receptors in human meningioma--a review.
Blankenstein MA; Koehorst SG; van der Kallen CJ; Jacobs HM; van Spriel AB; Donker GH; van't Verlaat JW; Blaauw G; Thijssen JH
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):361-5. PubMed ID: 7626481
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue.
Koehorst SG; Cox JJ; Donker GH; Lopes da Silva S; Burbach JP; Thijssen JH; Blankenstein MA
Mol Cell Endocrinol; 1994 May; 101(1-2):237-45. PubMed ID: 9397958
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
[TBL] [Abstract][Full Text] [Related]
10. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells.
Miksicek RJ; Lei Y; Wang Y
Breast Cancer Res Treat; 1993; 26(2):163-74. PubMed ID: 8219253
[TBL] [Abstract][Full Text] [Related]
11. Presence of alternatively spliced-estrogen receptor mRNA variants in normal human uterine endometrium and endometrial cancer.
Hirata S; Yamada-Mouri N; Nara M; Takizawa M; Ito H; Kato J
Endocr J; 1995 Apr; 42(2):289-93. PubMed ID: 7542977
[TBL] [Abstract][Full Text] [Related]
12. Aberrant oestrogen receptor species in human meningioma tissue.
Koehorst SG; Jacobs HM; Tilanus MG; Bouwens AG; Thijssen JH; Blankenstein MA
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):57-61. PubMed ID: 1525066
[TBL] [Abstract][Full Text] [Related]
13. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
Chan CM; Dowsett M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
[TBL] [Abstract][Full Text] [Related]
14. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of alternatively spliced estrogen and progesterone receptor transcripts in human breast cancer.
Balleine RL; Hunt SM; Clarke CL
J Clin Endocrinol Metab; 1999 Apr; 84(4):1370-7. PubMed ID: 10199781
[TBL] [Abstract][Full Text] [Related]
16. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
17. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.
Zhang QX; Hilsenbeck SG; Fuqua SA; Borg A
J Steroid Biochem Mol Biol; 1996 Nov; 59(3-4):251-60. PubMed ID: 9010317
[TBL] [Abstract][Full Text] [Related]
18. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
19. Identification of a dominant negative form of the human estrogen receptor.
Wang Y; Miksicek RJ
Mol Endocrinol; 1991 Nov; 5(11):1707-15. PubMed ID: 1779972
[TBL] [Abstract][Full Text] [Related]
20. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.
Fuqua SA; Allred DC; Elledge RM; Krieg SL; Benedix MG; Nawaz Z; O'Malley BW; Greene GL; McGuire WL
Breast Cancer Res Treat; 1993; 26(2):191-202. PubMed ID: 8219256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
